- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Outreach
- Careers
- About
- For Pain Patients and Professionals
Papers: 10 Jul 2021 - 16 Jul 2021
Pharmacology/Drug Development
PAIN TYPE:
Migraine/Headache
2021 Jul 15
Expert Opin Emerg Drugs
Migraine is a common and disabling neurological disorder. A greater understanding of the pathophysiological mechanisms underlying migraine has led to the availability of specific new drugs targeting calcitonin gene-related peptide (CGRP). The success of the CGRP inhibitors validates research efforts into migraine-specific therapies.